DaVita Inc., the nation’s second largest dialysis company, announced the completion of its $689 million purchase of DSI Renal, Inc. after agreeing to an FTC consent order to divest 29 clinics....

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch